A popular muscle relaxer made in New Jersey is being recalled due to a label swap, according to the FDA. The product was ...

Inflammatory arthritis resulting from immune checkpoint inhibitor use is immunologically unique and likely driven by T cells ...

Researchers at the University of Surrey developed an AI that predicts what a person’s knee X-ray will look like in a year, ...

Shaky hands? Mobility challenges? These beauty brands are making easier-to-apply makeup and clever brushes.

Arthritis affects more than 10 million people in the UK – roughly one-sixth of the population. It can be a painful, even debilitating, condition that affects people’s ability to perform and/or enjoy a ...

Please provide your email address to receive an email when new articles are posted on . The FDA expanded the indication for Tremfya (guselkumab) to children with plaque psoriasis or active psoriatic ...

A sweeping analysis of nearly 10,000 patients reveals that knee braces, hydrotherapy, and exercise stand out as the most effective non-drug therapies for knee osteoarthritis. Unlike common pain ...

A recent study reveals that rheumatoid arthritis (RA) begins years before joint pain manifests, with the immune system initiating a silent attack. This early immune system activity, marked by ...

As an editor and writer who has contributed to many national and local publications, Nicole Gregory enjoys communicating clearly on critical health topics so that readers can make informed choices for ...

At week 52 in a randomized, controlled trial, results suggest that tocilizumab is more effective than methotrexate in ...

Tremfya is the first IL-23 inhibitor approved for pediatric plaque psoriasis and psoriatic arthritis, based on the PROTOSTAR trial's positive results. The PROTOSTAR trial demonstrated significant skin ...

Topline data were announced from a phase 3 trial evaluating secukinumab in patients with polymyalgia rheumatica.